Monarch Partners Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.23M | Buy |
113,788
+27,003
| +31% | +$528K | 0.66% | 70 |
|
|
2022
Q3 | $1.39M | Buy |
+86,785
| New | +$1.39M | 0.42% | 115 |
|
|
2020
Q4 | – | Sell |
-26,090
| Closed | -$596K | – | 206 |
|
|
2020
Q3 | $596K | Buy |
26,090
+8,410
| +48% | +$192K | 0.13% | 141 |
|
|
2020
Q2 | $370K | Buy |
+17,680
| New | +$370K | 0.09% | 153 |
|
|
2018
Q4 | – | Sell |
-11,897
| Closed | -$293K | – | 203 |
|
|
2018
Q3 | $293K | Sell |
11,897
-3,085
| -21% | -$76K | 0.03% | 190 |
|
|
2018
Q2 | $294K | Hold |
14,982
| – | – | 0.03% | 187 |
|
|
2018
Q1 | $281K | Buy |
+14,982
| New | +$281K | 0.03% | 187 |
|